Richard Scott Struthers - Jun 16, 2023 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Signature
/s/ Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Jun 16, 2023
Transactions value $
-$1,040,500
Form type
4
Date filed
6/21/2023, 05:27 PM
Previous filing
Mar 17, 2023
Next filing
Jul 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Sale -$1.04M -50K -6.84% $20.81 681K Jun 16, 2023 By Family Trust 1
holding CRNX Common Stock 126K Jun 16, 2023 Direct
holding CRNX Common Stock 1K Jun 16, 2023 By Spouse
holding CRNX Common Stock 90K Jun 16, 2023 By Family Trust 2
holding CRNX Common Stock 90K Jun 16, 2023 By Family Trust 3
holding CRNX Common Stock 90K Jun 16, 2023 By Family Trust 4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).